My Quote Request
No products added yet
6505-01-529-5618
20 Products
NDC00009-7376-04
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505015295618
NSN
6505-01-529-5618
NDC00009-7376-04
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505015295618
NSN
6505-01-529-5618
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 683200
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP 150MG/ML PREFILLED 1ML SYRINGE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: PREFILLED SYRINGE
SPECIAL FEATURES: PREFILLED SYRINGES ARE AVAILABLE WITH 22 GAUGE X 1 1/2 BD SAFETY GLIDE NEEDLES; STORE AT CONTROLLED ROOM TEMP 20 TO 25 DEGREE C
Related Searches:
DEPO-PROVERA CI
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505015295618
NSN
6505-01-529-5618
DEPO-PROVERA CI
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505015295618
NSN
6505-01-529-5618
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 683200
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP 150MG/ML PREFILLED 1ML SYRINGE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: PREFILLED SYRINGE
SPECIAL FEATURES: PREFILLED SYRINGES ARE AVAILABLE WITH 22 GAUGE X 1 1/2 BD SAFETY GLIDE NEEDLES; STORE AT CONTROLLED ROOM TEMP 20 TO 25 DEGREE C
Related Searches:
05-0488
TERBUTALINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015296047
NSN
6505-01-529-6047
05-0488
TERBUTALINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015296047
NSN
6505-01-529-6047
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS TERBUTALINE SULFATE PER MILLILITER
ADMINISTRATION: SUBCUTANEOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 121200
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERBUTALINE SULFATE INJECTION USP 1MG/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: INDICATED FOR PREVENTION AND REVERSAL OF BRONCHOSPASM IN PATIENTS 12YRS OF AGE AND OLDER WITH ASTHMA AND REVERSIBLE BRONCHOSPASM ASSOCIATED WITH BRONCHITIS AND EMPHYSEMA, PROTECT FROM LIGHT BY STORING VIALS IN ORIGINAL CARTON UNTIL DISPENSED, DO NOT USE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: IF SOLUTION IS DISCOLORED, DISCARD UNUSED PORTION AFTER SINGLE PATIENT USE
Related Searches:
NDC55390-0101-10
TERBUTALINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015296047
NSN
6505-01-529-6047
NDC55390-0101-10
TERBUTALINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015296047
NSN
6505-01-529-6047
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS TERBUTALINE SULFATE PER MILLILITER
ADMINISTRATION: SUBCUTANEOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 121200
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERBUTALINE SULFATE INJECTION USP 1MG/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: INDICATED FOR PREVENTION AND REVERSAL OF BRONCHOSPASM IN PATIENTS 12YRS OF AGE AND OLDER WITH ASTHMA AND REVERSIBLE BRONCHOSPASM ASSOCIATED WITH BRONCHITIS AND EMPHYSEMA, PROTECT FROM LIGHT BY STORING VIALS IN ORIGINAL CARTON UNTIL DISPENSED, DO NOT USE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: IF SOLUTION IS DISCOLORED, DISCARD UNUSED PORTION AFTER SINGLE PATIENT USE
Related Searches:
05-0487
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
05-0487
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT
ADMINISTRATION: OTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: 1 PERCENT HYDROCORTISONE AND 2 PERCENT ACETIC ACID OTIC SOLUTION USP 10ML PLASTIC DROPPER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ACETASOL
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
ACETASOL
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
MFG
ALPHARMA US PHARMACEUTICALS DIVISION DBA ALPHARMA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT
ADMINISTRATION: OTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: 1 PERCENT HYDROCORTISONE AND 2 PERCENT ACETIC ACID OTIC SOLUTION USP 10ML PLASTIC DROPPER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00472-0882-82
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
NDC00472-0882-82
HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505015296094
NSN
6505-01-529-6094
MFG
ALPHARMA US PHARMACEUTICALS DIVISION DBA ALPHARMA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT
ADMINISTRATION: OTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: 1 PERCENT HYDROCORTISONE AND 2 PERCENT ACETIC ACID OTIC SOLUTION USP 10ML PLASTIC DROPPER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
05-0844
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 500MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE BELOW 30 DEGREES C, 86 DEGREES F; THIS ITEM NOT PROCURABLE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, BOTTLE 30S
Related Searches:
6505NCM050901
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
6505NCM050901
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 500MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE BELOW 30 DEGREES C, 86 DEGREES F; THIS ITEM NOT PROCURABLE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, BOTTLE 30S
Related Searches:
CIPRO
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 500MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE BELOW 30 DEGREES C, 86 DEGREES F; THIS ITEM NOT PROCURABLE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, BOTTLE 30S
Related Searches:
CIPRO-TABS, 30'S
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
CIPRO-TABS, 30'S
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505015296640
NSN
6505-01-529-6640
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 500MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE BELOW 30 DEGREES C, 86 DEGREES F; THIS ITEM NOT PROCURABLE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, BOTTLE 30S
Related Searches:
05-0843
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505015296773
NSN
6505-01-529-6773
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 UNITS OXYTOCIN PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 760000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYTOCIN INJECTION 10 UNITS/ML MULTI-DOSE 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 UNITS PER ML; 10ML MULTIPLE DOSE VIAL; 25S
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0012-10
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505015296773
NSN
6505-01-529-6773
NDC63323-0012-10
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505015296773
NSN
6505-01-529-6773
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 UNITS OXYTOCIN PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 760000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYTOCIN INJECTION 10 UNITS/ML MULTI-DOSE 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 UNITS PER ML; 10ML MULTIPLE DOSE VIAL; 25S
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
05-0804
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015301765
NSN
6505-01-530-1765
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 801202
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.25ML DOSE SYRINGE-UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: SPLIT SURFACE ANTIGEN ONLY; PRESERVATIVE-FREE; 0.25ML SYRINGE (PEDIATRIC), 10'S; SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6-35 MONTHS OF AGE; FOR 2005-2006 FLU SEASON; VIRUS STRAINA/NEW CALEDONIA/20/1999
VALENCE: TRIVALENT
~1: (H1N1)-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHI/361/2002-LIKE; DO NOT USE IF IT HAS BEEN FROZEN
Related Searches:
NDC49281-0005-25
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015301765
NSN
6505-01-530-1765
NDC49281-0005-25
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015301765
NSN
6505-01-530-1765
MFG
SANOFI PASTEUR INC.
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 801202
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.25ML DOSE SYRINGE-UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: SPLIT SURFACE ANTIGEN ONLY; PRESERVATIVE-FREE; 0.25ML SYRINGE (PEDIATRIC), 10'S; SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6-35 MONTHS OF AGE; FOR 2005-2006 FLU SEASON; VIRUS STRAINA/NEW CALEDONIA/20/1999
VALENCE: TRIVALENT
~1: (H1N1)-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHI/361/2002-LIKE; DO NOT USE IF IT HAS BEEN FROZEN
Related Searches:
05-0859
EFAVIRENZ TABLETS
NSN, MFG P/N
6505015302674
NSN
6505-01-530-2674
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EFAVIRENZ TABS 600MG SUSTIVA BT 30S
SPECIAL FEATURES: 600MG EFAVIRENZ,30 TABS; FOR TREATMENT OF PEOPLE INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; STORE AT ROOM TEMPERATURE,77 DEG. F; BT OF 30TABS
Related Searches:
NDC00056-0510-30
EFAVIRENZ TABLETS
NSN, MFG P/N
6505015302674
NSN
6505-01-530-2674
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EFAVIRENZ TABS 600MG SUSTIVA BT 30S
SPECIAL FEATURES: 600MG EFAVIRENZ,30 TABS; FOR TREATMENT OF PEOPLE INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; STORE AT ROOM TEMPERATURE,77 DEG. F; BT OF 30TABS
Related Searches:
SUSTIVA
EFAVIRENZ TABLETS
NSN, MFG P/N
6505015302674
NSN
6505-01-530-2674
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EFAVIRENZ TABS 600MG SUSTIVA BT 30S
SPECIAL FEATURES: 600MG EFAVIRENZ,30 TABS; FOR TREATMENT OF PEOPLE INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; STORE AT ROOM TEMPERATURE,77 DEG. F; BT OF 30TABS
Related Searches:
05-0873
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505015302679
NSN
6505-01-530-2679
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280892
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABS 325MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: 325MG ACETAMINOPHEN TABS; 100 PER BOTTLE
Related Searches:
NDC10135-0123-01
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505015302679
NSN
6505-01-530-2679
NDC10135-0123-01
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505015302679
NSN
6505-01-530-2679
MFG
MARLEX PHARMACEUTICALS INC.
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280892
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABS 325MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: 325MG ACETAMINOPHEN TABS; 100 PER BOTTLE
